Most epidemiologic studies of risk factors for Alzheimer's disease are limited to clinically diagnosed disease. This epidemiologic study proposes to continue investigating the pathologic mechanisms linking risk factors to the clinical expression of Alzheimer's disease. In the initial funding period, we found that 1) the apolipoprotein E e4 allele increased risk of clinical disease through an association with Alzheimer's disease pathology; 2) education reduced the likelihood that Alzheimer's disease pathology was expressed clinically; 3) Alzheimer's disease pathology is more likely to be expressed as clinical disease in women than in men; and 4) cerebral infarcts made a separate contribution to dementia but did not increase the likelihood that Alzheimer's disease pathology is expressed clinically. We also found that risk factors for Alzheimer's disease and common age-related pathologic indices can affect some cognitive abilities while sparing others, suggesting that studies limited to global measures of cognition may miss potentially important associations. The present application proposes to investigate the pathologic mechanisms linking HMG CoA reductase inhibitors (statins) and diabetes to clinical disease and to investigate additional hypotheses aimed at understanding sex differences in the clinical expression of Alzheimer's disease pathology. The proposed study will continue to take advantage of the risk factor information, longitudinal quantitative clinical data collected proximate to death, and brain tissue available through the Religious Orders Study, which performs annual clinical evaluations on more than 900 older nuns, priests and brothers who have agreed to brain donation after death. Hypothesis testing requires collecting new post-mortem data and linking it to available risk factor information and clinical data in innovative analyses. The findings from the proposed study could have important implications for therapeutic intervention and the prevention of Alzheimer's disease. ? ?
| Arvanitakis, Zoe; Leurgans, Sue E; Fleischman, Debra A et al. (2018) Memory complaints, dementia, and neuropathology in older blacks and whites. Ann Neurol 83:718-729 |
| Capuano, Ana W; Wilson, Robert S; Leurgans, Sue E et al. (2018) Sigmoidal mixed models for longitudinal data. Stat Methods Med Res 27:863-875 |
| Felsky, Daniel; Patrick, Ellis; Schneider, Julie A et al. (2018) Polygenic analysis of inflammatory disease variants and effects on microglia in the aging brain. Mol Neurodegener 13:38 |
| Lamar, Melissa; Yu, Lei; Rubin, Leah H et al. (2018) APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults. Alzheimers Dement : |
| Dobbyn, Amanda; Huckins, Laura M; Boocock, James et al. (2018) Landscape of Conditional eQTL in Dorsolateral Prefrontal Cortex and Co-localization with Schizophrenia GWAS. Am J Hum Genet 102:1169-1184 |
| Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872 |
| Haljas, Kadri; Amare, Azmeraw T; Alizadeh, Behrooz Z et al. (2018) Bivariate Genome-Wide Association Study of Depressive Symptoms With Type 2 Diabetes and Quantitative Glycemic Traits. Psychosom Med 80:242-251 |
| Jansen, Willemijn J; Wilson, Robert S; Visser, Pieter Jelle et al. (2018) Age and the association of dementia-related pathology with trajectories of cognitive decline. Neurobiol Aging 61:138-145 |
| Tan, Chin Hong; Fan, Chun Chieh; Mormino, Elizabeth C et al. (2018) Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition. Acta Neuropathol 135:85-93 |
| Wilson, Robert S; Capuano, Ana W; Yu, Lei et al. (2018) Neurodegenerative disease and cognitive retest learning. Neurobiol Aging 66:122-130 |
Showing the most recent 10 out of 355 publications
